Overview

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimal antiviral treatment for lamivudine resistant hepatitis B patients.
Phase:
Phase 4
Details
Lead Sponsor:
Inje University
Collaborator:
Bukwang Pharmaceutical
Treatments:
Adefovir
Adefovir dipivoxil
Clevudine
Lamivudine